Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             604 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions Klasen, Benedikt

112-113 C p. 80-93
artikel
2 A brief history of the Society of Radiopharmaceutical Sciences Coenen, Heinz H.

112-113 C p. 31-34
artikel
3 Accuracy of [68Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology Fassbender, Thomas F.
2019
112-113 C p. 32-38
artikel
4 A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models Ferguson, Simon

112-113 C p. 74-83
artikel
5 A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models Zhang-Yin, Jules

112-113 C p. 88-95
artikel
6 A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts Cho, Hyungjun

112-113 C p. 11-19
artikel
7 A decade of ubiquicidin development for PET imaging of infection: A systematic review Marjanovic-Painter, Biljana

112-113 C p.
artikel
8 Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases Dyer, Michael R.

112-113 C p.
artikel
9 A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3 Man, Francis

112-113 C p. 31-40
artikel
10 Alanine and glycine conjugates of (2S,4R)-4-[18F]fluoroglutamine for tumor imaging Zha, Zhihao
2018
112-113 C p. 19-28
artikel
11 Al[18F]F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation Alonso Martinez, Luis Michel
2018
112-113 C p. 36-42
artikel
12 Alkaline degradation of lyophilized DMSA prior to labeling with 99mTc: Identification and development of the degradation pathway by HPLC and MS Almeida, Erika V.
2018
112-113 C p. 20-27
artikel
13 Alpha emitting nuclides for targeted therapy Hatcher-Lamarre, Jasmine L.

112-113 C p. 228-240
artikel
14 Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors Maina, Theodosia
2017
112-113 C p. 57-62
6 p.
artikel
15 A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor Petrulli, J. Ryan
2017
112-113 C p. 56-61
artikel
16 An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT) Baimukhanova, Ayagoz

112-113 C p. 35-43
artikel
17 An electrochemical approach for removal of radionuclidic contaminants of Eu from 153Sm for effective use in metastatic bone pain palliation Chakravarty, Rubel
2018
112-113 C p. 8-19
artikel
18 A new method measuring the interaction of radiotracers with the human P-glycoprotein (P-gp) transporter Vraka, Chrysoula
2018
112-113 C p. 29-36
artikel
19 An improved automated one-pot synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) based on a purification by cartridges Bogni, A.
2019
112-113 C p. 11-19
artikel
20 An original radio-biomimetic approach to synthesize radiometabolites for PET imaging Auvity, Sylvain

112-113 C p. 10-14
artikel
21 A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation Tekin, Volkan

112-113 C p. 20-31
artikel
22 Applying radiobiology to clinical molecular radiotherapy Murray, Iain

112-113 C p. 1-3
artikel
23 Approaches to improve metabolic stability of a statine-based GRP receptor antagonist Popp, Ilinca
2017
112-113 C p. 22-29
8 p.
artikel
24 A preliminary biodistribution study of [99mTc]sodium pertechnetate prepared from an electron linear accelerator and activated carbon-based 99mTc generator Jang, Jaewoong

112-113 C p. 1-9
artikel
25 A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy Destro, Gianluca

112-113 C p.
artikel
26 A radiopharmaceutical [89Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo Tang, Yu
2019
112-113 C p. 23-31
artikel
27 A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals Sharma, Sai Kiran
2019
112-113 C p. 32-38
artikel
28 A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept Chen, Wen

112-113 C p. 107-114
artikel
29 A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications Mastren, Tara

112-113 C p. 69-73
artikel
30 Aryl isocyanide derivative for one-pot synthesis of purification-free 99mTc-labeled hexavalent targeting probe Mizuno, Yuki

112-113 C p. 30-36
artikel
31 A simple device to convert a small-animal PET scanner into a multi-sample tissue and injection syringe counter Green, Michael V.
2017
112-113 C p. 9-13
5 p.
artikel
32 A six-year longitudinal PET study of (+)-[11C]DTBZ binding to the VMAT2 in monkey brain Kilbourn, Michael R.
2017
112-113 C p. 34-37
artikel
33 Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging Singh, Nisha
2018
112-113 C p. 32-39
artikel
34 Assessment of drug transporters involved in the urinary secretion of [99mTc]dimercaptosuccinic acid Kobayashi, Masato

112-113 C p. 92-97
artikel
35 Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+ and 225Ac3+ Kelly, James M.
2017
112-113 C p. 38-46
artikel
36 Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer Michalski, Kerstin

112-113 C p. 37-43
artikel
37 Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation Choi, Jaeyeon
2018
112-113 C p. 10-20
artikel
38 Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy Ogawa, Kazuma

112-113 C p.
artikel
39 211At labeled substance P (5–11) as potential radiopharmaceutical for glioma treatment Lyczko, Monika
2017
112-113 C p. 1-8
8 p.
artikel
40 A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability Feng, Yutian
2018
112-113 C p. 1-10
artikel
41 Auger electron therapy of glioblastoma using [125I]5-iodo-2′-deoxyuridine and concomitant chemotherapy – Evaluation of a potential treatment strategy Madsen, Karina Lindbøg

112-113 C p. 35-40
artikel
42 Auger: The future of precision medicine Pirovano, Giacomo

112-113 C p. 50-53
artikel
43 A useful PET probe [11C]BU99008 with ultra-high specific radioactivity for small animal PET imaging of I2-imidazoline receptors in the hypothalamus Kawamura, Kazunori
2017
112-113 C p. 1-7
7 p.
artikel
44 Automated production of [11C]butyrate for keto body PET imaging Pakula, Ryan J.

112-113 C p.
artikel
45 Automated production of [18F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors Lindner, Simon

112-113 C p. 86-95
artikel
46 Automated radiosynthesis and preclinical evaluation of Al[18F]F-NOTA-P-GnRH for PET imaging of GnRH receptor-positive tumors Huang, Shun

112-113 C p. 64-71
artikel
47 Automated radiosynthesis and preclinical in vivo evaluation of [18F]Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET Ramakrishnan, Nisha K.

112-113 C p. 71-77
artikel
48 Automated radiosynthesis of 5-[11C]l-glutamine, an important tracer for glutamine utilization Rosenberg, Adam J.
2018
112-113 C p. 10-14
artikel
49 Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo Wichmann, Christian W.

112-113 C p.
artikel
50 Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans Caillé, Fabien

112-113 C p. 20-27
artikel
51 Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images Cysouw, Matthijs C.F.
2017
112-113 C p. 18-24
7 p.
artikel
52 B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models Kasten, Benjamin B.
2017
112-113 C p. 23-30
artikel
53 Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[18F]fluoro-phenylalanine: A comparative PET/CT study with L-isomer in healthy human volunteers Yang, Qiao

112-113 C p. 32-37
artikel
54 Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies Doot, Robert K.

112-113 C p. 1-8
artikel
55 Biodistribution study of 211Pb progeny released from intravenously applied 223Ra labelled TiO2 nanoparticles in a mouse model Sakmár, Michal

112-113 C p.
artikel
56 Biokinetics, radiopharmacokinetics and estimation of the absorbed dose in healthy organs due to Technetium-99m transported in the core and on the surface of reconstituted high-density lipoprotein nanoparticles Pérez-Velasco, Diana L.

112-113 C p.
artikel
57 Biological evaluation of a novel stable peptide PET molecular probe [18F]AlF-NOTA-DVAP targeting to tumor cell surface GRP78 Yao, Bolin

112-113 C p.
artikel
58 Biologicals as theranostic vehicles in paediatric oncology Niessen, Veerle J.A.

112-113 C p. 58-64
artikel
59 Bismuth chelation for targeted alpha therapy: Current state of the art Franchi, Sara

112-113 C p. 168-188
artikel
60 Blood and urine analyses after radioembolization of liver malignancies with [166Ho]Ho-acetylacetonate-poly(l-lactic acid) microspheres Bakker, Robbert C.
2019
112-113 C p. 11-18
artikel
61 BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain van der Wildt, Berend

112-113 C p. 44-51
artikel
62 Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents Ogata, Aya

112-113 C p. 52-58
artikel
63 Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety Hu, Kun
2017
112-113 C p. 43-50
8 p.
artikel
64 Brown adipose tissue imaging using the TSPO tracer [18F]fluoromethyl-PBR28-d 2: A comparison with [18F]FDG Oh, Chiwoo

112-113 C p. 98-103
artikel
65 Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors Vaidyanathan, Ganesan

112-113 C p. 18-30
artikel
66 Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam Mastren, Tara
2017
112-113 C p. 24-29
artikel
67 Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis Meletta, Romana
2017
112-113 C p. 31-43
artikel
68 [11C]AZ10419096 – a full antagonist PET radioligand for imaging brain 5-HT1B receptors Lindberg, Anton
2017
112-113 C p. 34-40
7 p.
artikel
69 Cell death PET/CT imaging of rat hepatic fibrosis with 18F-labeled small molecule tracer Su, Shu

112-113 C p. 76-83
artikel
70 [11C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice Traxl, Alexander
2017
112-113 C p. 7-15
9 p.
artikel
71 Characterization of actinide resin for separation of 51,52gMn from bulk target material Barrett, Kendall E.

112-113 C p. 19-26
artikel
72 Characterization of a S1PR2 specific 11C-labeled radiotracer in streptozotocin-induced diabetic murine model Jiang, Hao

112-113 C p.
artikel
73 Chelation chemistry of manganese-52 for PET imaging applications Omweri, James M.

112-113 C p.
artikel
74 Clinical evaluation of [68Ga]Ga-DATA-TOC in comparison to [68Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours Gaertner, F.C.

112-113 C p. 1-9
artikel
75 Clinical 68Ga-PET: Is radiosynthesis module an absolute necessity? Chakravarty, Rubel
2017
112-113 C p. 1-11
11 p.
artikel
76 Clinical results and economic considerations of 68Ga-PSMA and radiolabeled choline in prostate cancer Evangelista, Laura
2017
112-113 C p. 47-49
artikel
77 Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized 198Au nanoparticles for targeted cancer therapy Chakravarty, Rubel
2019
112-113 C p. 1-10
artikel
78 Clinical translation of a PSMA inhibitor for 99mTc-based SPECT Ferro-Flores, Guillermina
2017
112-113 C p. 36-44
9 p.
artikel
79 Clinical usefulness of 18F–FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis Lefebvre, Nicolas
2017
112-113 C p. 17-24
artikel
80 Combination radionuclide therapy: A new paradigm Suman, Shishu Kant

112-113 C p. 40-58
artikel
81 Commentary Eckelman, William C.
2017
112-113 C p. 1-3
3 p.
artikel
82 Comparative evaluation of [18F]DiFA and its analogs as novel hypoxia positron emission tomography and [18F]FMISO as the standard Nakata, Norihito
2019
112-113 C p. 39-45
artikel
83 Comparison between [18F]fluorination and [18F]fluoroethylation reactions for the synthesis of the PDE10A PET radiotracer [18F]MNI-659 Mori, Wakana
2017
112-113 C p. 12-18
artikel
84 Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches Feiner, Irene V.J.

112-113 C p. 24-33
artikel
85 Comparison of 68Ga-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold Kaeopookum, Piriya

112-113 C p. 1-10
artikel
86 Comparison of planar, PET and well-counter measurements of total tumor radioactivity in a mouse xenograft model Green, Michael V.
2017
112-113 C p. 29-36
8 p.
artikel
87 Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA) Chang, Ting-Yu

112-113 C p.
artikel
88 Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cells Garg, Ravendra

112-113 C p. 80-88
artikel
89 Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation Krohn, Kenneth A.

112-113 C p. 5-23
artikel
90 Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight Coenen, Heinz H.
2017
112-113 C p. v-xi
artikel
91 Contents
112-113 C p. OBC
artikel
92 Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies Amor-Coarasa, Alejandro
2017
112-113 C p. 37-39
3 p.
artikel
93 Contribution of neuroinflammation to changes in [11C]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue Parente, Andrea
2017
112-113 C p. 50-56
artikel
94 Co-production of 155Tb and 152Tb irradiating 155Gd / 151Eu tandem target with a medium energy α-particle beam Moiseeva, A.N.

112-113 C p.
artikel
95 Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy? Chia, Kazumi

112-113 C p. 10-17
artikel
96 Corrigendum to “131I-labeled chitosan hydrogels for radioembolization: a preclinical study in small animals” [Nucl Med Biol 52 (2017) 16–23] Hwang, Hyosook
2018
112-113 C p. 50
artikel
97 Corrigendum to ‘212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models’ [Nucl Med Biol 58 (2018) 67–73] Kasten, Benjamin B.
2018
112-113 C p. 71
artikel
98 Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] Stergiou, N.

112-113 C p. 65
artikel
99 [11C]PF-3274167 as a PET radiotracer of oxytocin receptors: Radiosynthesis and evaluation in rat brain Vidal, Benjamin
2017
112-113 C p. 1-6
artikel
100 [11C]phosgene: Synthesis and application for development of PET radiotracers Fukumura, Toshimitsu

112-113 C p. 138-148
artikel
101 Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV Sinharay, Sanhita
2017
112-113 C p. 27-33
artikel
102 64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: An untapped, cost-effective and high energy production route Nelson, Bryce J.B.

112-113 C p.
artikel
103 Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology Stegmayr, Carina

112-113 C p. 78-84
artikel
104 Cyclotron production of 68Ga in a liquid target: Effects of solution composition and irradiation parameters Pandey, Mukesh K.

112-113 C p. 49-55
artikel
105 Cyclotron production of 99mTc Gumiela, Magdalena
2018
112-113 C p. 33-41
artikel
106 Cyclotron production of 103Pd using a liquid target Krol, Viktoria

112-113 C p.
artikel
107 Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT Jiang, Donglang

112-113 C p. 89-95
artikel
108 Delivery systems exploiting natural cell transport processes of macromolecules for intracellular targeting of Auger electron emitters Rosenkranz, Andrey A.

112-113 C p. 45-56
artikel
109 Demystifying solid targets: Simple and rapid distribution-scale production of [68Ga]GaCl3 and [68Ga]Ga-PSMA-11 Svedjehed, Johan

112-113 C p. 1-10
artikel
110 Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue Goos, Jeroen A.C.M.

112-113 C p. 63-72
artikel
111 Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors Lever, John R.
2019
112-113 C p. 53-66
artikel
112 Detection of melanoma metastases with PET—Comparison of 18F-5-FPN with 18F–FDG Wang, Yichun
2017
112-113 C p. 33-38
artikel
113 Deuterated [18F]fluoroethyl tropane analogs as dopamine transporter probes: Synthesis and biological evaluation Li, Qingming

112-113 C p.
artikel
114 Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent Liu, Futao
2018
112-113 C p. 42-49
artikel
115 Developing new PET tracers to image the growth hormone secretagogue receptor 1a (GHS-R1a) Kawamura, Kazunori
2017
112-113 C p. 49-56
8 p.
artikel
116 Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2 Ma, Li

112-113 C p. 61-69
artikel
117 Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications Klasen, Benedikt

112-113 C p. 12-23
artikel
118 Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations Radzik, Marcin

112-113 C p. 63-73
artikel
119 Development of 225Ac/213Bi generator based on α-ZrP-PAN composite for targeted alpha therapy Ondrák, Lukáš

112-113 C p.
artikel
120 Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET Zhang, Xiaohui

112-113 C p.
artikel
121 Development of a 18F-labeled PET radioligand for imaging 5-HT1B receptors: [18F]AZ10419096 Lindberg, Anton

112-113 C p. 11-16
artikel
122 Development of a novel radiobromine-labeled sigma-1 receptor imaging probe Ogawa, Kazuma
2018
112-113 C p. 28-35
artikel
123 Development of a PET radioligand selective for cerebral amyloid angiopathy Abrahamson, Eric E.

112-113 C p. 85-96
artikel
124 Development of a preclinical 211Rn/211At generator system for targeted alpha therapy research with 211At Crawford, Jason R.
2017
112-113 C p. 31-35
5 p.
artikel
125 Development of a thin layer chromatography method for plasma correction of [18F]fluorocholine metabolites in positron emission tomography quantification studies in humans Villar, Marina

112-113 C p. 34-40
artikel
126 Development of [11C]/[3H]THK-5351 – A potential novel carbon-11 tau imaging PET radioligand Stepanov, Vladimir
2017
112-113 C p. 50-53
4 p.
artikel
127 Development of [18F]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands Bongarzone, Salvatore
2019
112-113 C p. 14-21
artikel
128 Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase van der Wildt, Berend
2017
112-113 C p. 90-104
15 p.
artikel
129 Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes Saito, Kosuke

112-113 C p. 72-79
artikel
130 Development of radioiodine labeled acetaminophen for specific, high-contrast imaging of malignant melanoma Zhu, Wen Jing
2018
112-113 C p. 16-21
artikel
131 Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers Kumar, Dheeraj

112-113 C p. 1-10
artikel
132 Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates Stepanov, Vladimir
2018
112-113 C p. 12-19
artikel
133 (1→3)-β-D-glucan aptamers labeled with technetium-99m: Biodistribution and imaging in experimental models of bacterial and fungal infection de Sousa Lacerda, Camila Maria
2017
112-113 C p. 19-24
6 p.
artikel
134 Differences in accumulation and the transport mechanism of l- and d-methionine in high- and low-grade human glioma cells Kobayashi, Masato
2017
112-113 C p. 78-82
5 p.
artikel
135 Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist Ahenkorah, Stephen

112-113 C p.
artikel
136 Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation Wang, Jing

112-113 C p. 46-52
artikel
137 Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain van der Wildt, Berend

112-113 C p. 99-107
artikel
138 Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold He, Yingfang

112-113 C p. 24-32
artikel
139 Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy Bastiani, Isabella

112-113 C p. 10-20
artikel
140 Dose-on-demand production of diverse 18F-radiotracers for preclinical applications using a continuous flow microfluidic system Matesic, Lidia
2017
112-113 C p. 24-31
8 p.
artikel
141 DOTA-tetrazine probes with modified linkers for tumor pretargeting Läppchen, Tilman
2017
112-113 C p. 19-26
artikel
142 Do we say what we mean and mean what we say? Coenen, Heinz H.
2017
112-113 C p. 53-54
2 p.
artikel
143 Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer Staniszewska, Magdalena

112-113 C p. 101-111
artikel
144 Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours Knight, James C.
2019
112-113 C p. 14-22
artikel
145 Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs de Lange, Charlotte
2018
112-113 C p. 49-57
artikel
146 Editorial Board 2017
112-113 C p. IFC-
1 p.
artikel
147 Editorial Board 2017
112-113 C p. IFC-
1 p.
artikel
148 Editorial Board 2017
112-113 C p. IFC-
1 p.
artikel
149 Editorial Board 2017
112-113 C p. IFC-
1 p.
artikel
150 Editorial Board
112-113 C p. ii
artikel
151 Editorial Board
112-113 C p. ii
artikel
152 Editorial Board
112-113 C p. ii
artikel
153 Editorial Board 2017
112-113 C p. IFC-
1 p.
artikel
154 Editorial Board 2017
112-113 C p. IFC-
1 p.
artikel
155 Editorial Board 2018
112-113 C p. IFC
artikel
156 Editorial Board 2018
112-113 C p. IFC
artikel
157 Editorial Board 2018
112-113 C p. IFC
artikel
158 Editorial Board
112-113 C p. IFC
artikel
159 Editorial Board
112-113 C p. IFC
artikel
160 Editorial Board 2017
112-113 C p. IFC
artikel
161 Editorial Board 2017
112-113 C p. IFC
artikel
162 Editorial Board 2017
112-113 C p. IFC
artikel
163 Editorial Board 2018
112-113 C p. IFC
artikel
164 Editorial Board 2017
112-113 C p. IFC-
1 p.
artikel
165 Editorial Board 2017
112-113 C p. IFC-
1 p.
artikel
166 Editorial Board 2017
112-113 C p. IFC
artikel
167 Editorial Board 2018
112-113 C p. IFC
artikel
168 Editorial Board 2018
112-113 C p. IFC
artikel
169 Editorial Board 2019
112-113 C p. ii
artikel
170 Editorial Board 2018
112-113 C p. IFC
artikel
171 Editorial Board 2018
112-113 C p. IFC
artikel
172 Editorial Board 2019
112-113 C p. ii
artikel
173 Editorial Board 2019
112-113 C p. ii
artikel
174 Editorial Board 2019
112-113 C p. ii
artikel
175 Editorial Board
112-113 C p. ii
artikel
176 Editorial Board
112-113 C p. ii
artikel
177 Editorial Board
112-113 C p. ii
artikel
178 Editorial Board
112-113 C p. ii
artikel
179 Editorial Board
112-113 C p. ii
artikel
180 Editorial Board
112-113 C p. ii
artikel
181 Editorial Board
112-113 C p. ii
artikel
182 Editorial Board
112-113 C p. ii
artikel
183 Editorial Board
112-113 C p. ii
artikel
184 Editorial Board
112-113 C p. ii
artikel
185 Editorial Board
112-113 C p. ii
artikel
186 Editorial Board
112-113 C p. ii
artikel
187 Editorial Board
112-113 C p. ii
artikel
188 Editorial Board
112-113 C p. ii
artikel
189 Editorial Board
112-113 C p. ii
artikel
190 Editorial Board
112-113 C p. ii
artikel
191 Editorial Board
112-113 C p. ii
artikel
192 Editorial Board
112-113 C p.
artikel
193 Editorial Board
112-113 C p.
artikel
194 Editorial Board
112-113 C p.
artikel
195 Editorial Board
112-113 C p. ii
artikel
196 Editorial Board
112-113 C p.
artikel
197 Editorial Board
112-113 C p. ii
artikel
198 Editorial Board
112-113 C p.
artikel
199 Editorial Board
112-113 C p.
artikel
200 Editorial Board
112-113 C p.
artikel
201 Editorial Board
112-113 C p.
artikel
202 Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR Chan, Conrad

112-113 C p. 37-44
artikel
203 Effect of methoxy group position on biological properties of 18F–labeled benzyl triphenylphosphonium cations Chen, Shuting
2017
112-113 C p. 16-23
artikel
204 Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE Rousseau, Etienne
2018
112-113 C p. 10-17
artikel
205 Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-β PET ligands Tago, Tetsuro

112-113 C p. 38-45
artikel
206 Efficient cartridge purification for producing high molar activity [18F]fluoro-glycoconjugates via oxime formation Keinänen, Outi
2018
112-113 C p. 27-35
artikel
207 Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid Kanai, Ayaka

112-113 C p. 47-52
artikel
208 Establishment of a method for in-vivo SPECT/CT imaging analysis of 111In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe Hamamatsu, Keita

112-113 C p. 22-27
artikel
209 Estimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer Green, Mark A.
2017
112-113 C p. 32-35
4 p.
artikel
210 Evaluation and selection of a lead diabody for interferon-γ PET imaging Rezazadeh, Farzaneh

112-113 C p. 162-167
artikel
211 Evaluation of [225Ac]Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma Cortez, Angel

112-113 C p. 62-72
artikel
212 Evaluation of a chloride-based 89Zr isolation strategy using a tributyl phosphate (TBP)-functionalized extraction resin Graves, Stephen A.

112-113 C p. 1-7
artikel
213 Evaluation of acute intravenous toxicity of HEPES: Is Good's buffer good and safe enough for clinical utilization in nuclear medicine? Guleria, Mohini

112-113 C p.
artikel
214 Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and 177Lu labeling Altai, Mohamed
2017
112-113 C p. 1-9
9 p.
artikel
215 Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26 Mansour, Nematallah
2018
112-113 C p. 31-38
artikel
216 Evaluation of a novel hexadentate 1,2-hydroxypyridinone-based acyclic chelate, HOPO-O6-C4, for 43Sc/47Sc, 68Ga, and 45Ti radiopharmaceuticals Carbo-Bague, Imma

112-113 C p.
artikel
217 Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system Wilson, Alan A.
2017
112-113 C p. 14-20
7 p.
artikel
218 Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac Bailey, Tyler A.

112-113 C p. 28-36
artikel
219 Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma Vermeulen, Koen

112-113 C p. 1-11
artikel
220 Evaluation of [18F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer Carlucci, Giuseppe
2017
112-113 C p. 9-15
7 p.
artikel
221 Evaluation of [18F]FDG/[18F]FLT/[18F]FMISO-based micro-positron emission tomography in detection of liver metastasis in human colorectal cancer Jiang, Hao
2019
112-113 C p. 36-44
artikel
222 Evaluation of [18F]FMTEB in Sprague Dawley rats as a PET tracer for metabotropic glutamate receptor 5 Krzyczmonik, Anna

112-113 C p.
artikel
223 Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats Salabert, Anne-Sophie
2018
112-113 C p. 1-8
artikel
224 Evaluation of [18F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function Yagi, Yusuke

112-113 C p. 25-31
artikel
225 Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine Shalgunov, Vladimir

112-113 C p.
artikel
226 Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII Fiedler, L.
2018
112-113 C p. 55-62
artikel
227 Evaluation of N-(6-[18F]Fluoropyridin-3-yl)glycine PET renography to detect renal function progression in a rat model of diabetic nephropathy Wang, Hongliang

112-113 C p. 59-65
artikel
228 Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer. Li, Yawen

112-113 C p. 217-227
artikel
229 Evaluation of sulfone-labeled amino acid derivatives as potential PET agents for cancer imaging Hu, Mei

112-113 C p.
artikel
230 Evaluation of targeting αVβ3 in breast cancers using RGD peptide-based agents Josefsson, Anders

112-113 C p.
artikel
231 Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors Honarvar, Hadis
2017
112-113 C p. 15-21
7 p.
artikel
232 Evaluation of the high affinity [18F]fluoropyridine-candesartan in rats for PET imaging of renal AT1 receptors Abreu Diaz, Aida M.

112-113 C p. 41-49
artikel
233 Evaluation of the α-synuclein PET radiotracer (d3)-[11C]MODAG-001 in pigs Raval, Nakul Ravi

112-113 C p. 42-48
artikel
234 Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-l-DOPA Pretze, Marc
2017
112-113 C p. 35-42
8 p.
artikel
235 Excitation function and yield for the 103Rh(d,2n)103Pd nuclear reaction: Optimization of the production of palladium-103 Manenti, Simone
2017
112-113 C p. 30-37
artikel
236 Excitatory glutamate transporter EAAC1 as an important transporter of N-(2-[18F]fluoropropionyl)-L-glutamate in oncology PET imaging Tang, Caihua

112-113 C p. 55-62
artikel
237 EXIRAD-3D: Fast automated three-dimensional autoradiography Nguyen, Minh Phuong

112-113 C p. 59-65
artikel
238 Expanding LogP: Present possibilities Vraka, Chrysoula
2018
112-113 C p. 20-32
artikel
239 Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18 Coenen, Heinz H.

112-113 C p. 241-269
artikel
240 Facile radiochemical separation of clinical-grade 90Y from 90Sr by selective precipitation for targeted radionuclide therapy Chakravarty, Rubel
2019
112-113 C p. 58-65
artikel
241 Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[18F]fluoropropyl)benzylguanidine ([18F]mFPBG) Woo, Sang-Keun
2018
112-113 C p. 63-70
artikel
242 Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain Fuchigami, Takeshi

112-113 C p. 41-48
artikel
243 [18F]FDG and [11C]PK11195 PET imaging in the evaluation of brown adipose tissue - effects of cold and pharmacological stimuli and their association with crotamine intake in a male mouse model de Paula Faria, Daniele

112-113 C p.
artikel
244 [18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease Keller, Thomas
2018
112-113 C p. 1-9
artikel
245 2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation Verhoeven, Jeroen

112-113 C p. 9-16
artikel
246 18F-fluoro-2-deoxyglucose PET informs neutrophil accumulation and activation in lipopolysaccharide-induced acute lung injury Rodrigues, Rosana S.
2017
112-113 C p. 52-62
11 p.
artikel
247 [18F]-GE-179 positron emission tomography (PET) tracer for N-methyl-d-aspartate receptors: One-pot synthesis and preliminary micro-PET study in a rat model of MCAO Zhou, Weiyan
2018
112-113 C p. 45-55
artikel
248 18F–labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer Xu, Duo
2018
112-113 C p. 48-55
artikel
249 18F-labeled ethisterone derivative for progesterone receptor targeted PET imaging of breast cancer Gao, Fei
2019
112-113 C p. 62-69
artikel
250 18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation Kirjavainen, Anna K.
2018
112-113 C p. 39-46
artikel
251 18F-Labeled perfluorocarbon droplets for positron emission tomography imaging Amir, Nagina
2017
112-113 C p. 27-33
7 p.
artikel
252 18F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2 Ackermann, Uwe

112-113 C p.
artikel
253 18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging Kwon, Young-Do

112-113 C p. 22-36
artikel
254 Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain Zhang, Yan
2018
112-113 C p. 1-9
artikel
255 Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging Demétrio de Souza França, Paula

112-113 C p. 80-87
artikel
256 Fluselenamyl: Evaluation of radiation dosimetry in mice and pharmacokinetics in brains of non-human primate Sundaram, G.S.M.

112-113 C p. 33-40
artikel
257 From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience Pouget, Jean-Pierre

112-113 C p. 53-64
artikel
258 [18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4 Amor-Coarasa, Alejandro
2018
112-113 C p. 37-44
artikel
259 Fully automated dual-run manufacturing of [11C]PIB on FASTlab Nair, Manoj

112-113 C p.
artikel
260 GABAa receptor density alterations revealed in a mouse model of early moderate prenatal ethanol exposure using [18F]AH114726 Nguyen, Van T.

112-113 C p. 44-51
artikel
261 [68Ga]Ga-DOTA-TOC PET/CT in the localization of head and neck paraganglioma compared with [18F]FDOPA PET/CT and [123I]MIBG SPECT/CT Kroiss, Alexander Stephan
2019
112-113 C p. 47-53
artikel
262 68Ga[Ga]-Galmydar: Biodistribution and radiation dosimetry studies in rodents Sivapackiam, Jothilingam
2018
112-113 C p. 29-35
artikel
263 [68Ga]Ga-HBED-CC-DiAsp: A new renal function imaging agent Shi, Shengyu

112-113 C p. 17-24
artikel
264 [68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging Rivera-Bravo, Belén

112-113 C p. 54-60
artikel
265 [68Ga]Ga-NOTA-MAL-Cys39-exendin-4, a potential GLP-1R targeted PET tracer for the detection of insulinoma Zhang, Pengjun

112-113 C p. 19-24
artikel
266 67Ga-labeled deferoxamine derivatives for imaging bacterial infection: Preparation and screening of functionalized siderophore complexes Ioppolo, Joseph A.
2017
112-113 C p. 32-41
10 p.
artikel
267 68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics Mittal, Sweety

112-113 C p. 61-67
artikel
268 68Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma Li, Linlin

112-113 C p. 87-96
artikel
269 68Ga-labelled NOTA-RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging Chen, Chien-Jen
2019
112-113 C p. 22-30
artikel
270 Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent Bhatt, Jyotsna

112-113 C p. 47-53
artikel
271 [68Ga]/[90Y]FAPI-46: Automated production and analytical validation of a theranostic pair Nader, M.

112-113 C p. 37-44
artikel
272 Gefitinib enhances radiotherapeutic effects of 131I–hEGF targeted to EGFR by increasing tumor uptake of hEGF in tumor xenografts Xia, Lu
2017
112-113 C p. 63-68
6 p.
artikel
273 GMP production of [68Ga]Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study Velikyan, Irina

112-113 C p. 73-85
artikel
274 Gold nanoparticles meet medical radionuclides Daems, Noami

112-113 C p. 61-90
artikel
275 Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET Andersen, Katrine B.

112-113 C p. 52-58
artikel
276 High-throughput radio-TLC analysis Wang, Jia

112-113 C p. 41-48
artikel
277 High-yield cyclotron production of 203Pb using a sealed 205Tl solid target Nelson, Bryce J.B.

112-113 C p.
artikel
278 HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study Follacchio, Giulia Anna

112-113 C p. 94-100
artikel
279 HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging Li, Ai-Mei

112-113 C p. 27-34
artikel
280 Human biodistribution and dosimetry of [18F]nifene, an α4β2* nicotinic acetylcholine receptor PET tracer Betthauser, Tobey J.
2017
112-113 C p. 7-11
artikel
281 Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine Frisch, Kim
2019
112-113 C p. 55-61
artikel
282 Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM Igarashi, Chika

112-113 C p. 10-15
artikel
283 131I-labeled chitosan hydrogels for radioembolization: A preclinical study in small animals Hwang, Hyosook
2017
112-113 C p. 16-23
8 p.
artikel
284 Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction Liu, Zhonglin
2019
112-113 C p. 67-77
artikel
285 Imaging diabetic cardiomyopathy in a type 1 diabetic rat model using 18F-FEPPA PET Hsieh, Hsin-Hua

112-113 C p.
artikel
286 Imaging niacin trafficking with positron emission tomography reveals in vivo monocarboxylate transporter distribution Bongarzone, Salvatore

112-113 C p. 24-33
artikel
287 Imaging of isoproterenol-induced myocardial injury with 18F labeled fluoroglucaric acid in a rat model Houson, Hailey A.
2018
112-113 C p. 9-15
artikel
288 Imaging of microglia in post-stroke inflammation Wang, Ze

112-113 C p.
artikel
289 Imaging of the third gasotransmitter hydrogen sulfide using 99mTc-labeled alpha-hydroxy acids Park, Ji Yong

112-113 C p. 28-35
artikel
290 Imaging thrombosis with 99mTc-labeled RAM.1-antibody in vivo Ouadi, Ali
2018
112-113 C p. 21-27
artikel
291 [131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma Kobayashi, Masato

112-113 C p. 49-54
artikel
292 Iminodiacetic acid as bifunctional linker for dimerization of cyclic RGD peptides Xu, Dong
2017
112-113 C p. 1-8
8 p.
artikel
293 Immuno-imaging of ICAM-1 in tumours by SPECT Mosley, Michael

112-113 C p. 73-79
artikel
294 Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma Wen, Xuejun

112-113 C p. 44-51
artikel
295 Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents Tietz, Ole

112-113 C p. 9-17
artikel
296 Improved production of 76Br, 77Br and 80mBr via CoSe cyclotron targets and vertical dry distillation Ellison, Paul A.

112-113 C p. 32-36
artikel
297 Improved purification of cyclotron [68Ga]GaCl3 for the production of 68Ga radiopharmaceuticals Wang, Ivan E.

112-113 C p.
artikel
298 Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons Kurakina, E.S.

112-113 C p. 22-27
artikel
299 Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging Ruivo, Eduardo

112-113 C p. 36-42
artikel
300 Improving metabolic stability of fluorine-18 labeled verapamil analogs Raaphorst, Renske M.

112-113 C p. 47-56
artikel
301 111In-DTPA-d-Phe−1-Asp0-d-Phe1-octreotide exhibits higher tumor accumulation and lower renal radioactivity than 111In-DTPA-d-Phe1-octreotide Oshima, Nobuhiro
2017
112-113 C p. 18-26
9 p.
artikel
302 Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor Schneider, Daniela

112-113 C p. 1-8
artikel
303 Influence of transport line material on the molar activity of cyclotron produced [18F]fluoride Savisto, Nina

112-113 C p. 8-15
artikel
304 Inhibition of viability of microorganisms in [18F]-labeled radiopharmaceuticals Jörg, G.
2017
112-113 C p. 105-113
9 p.
artikel
305 Intraarticular and intravenous administration of 99MTc-HMPAO-labeled human mesenchymal stem cells ( 99M TC-AH-MSC S ): In vivo imaging and biodistribution Meseguer-Olmo, Luis
2017
112-113 C p. 36-42
7 p.
artikel
306 Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptor Khalil, Amina

112-113 C p.
artikel
307 Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines Delbart, Wendy

112-113 C p. 68-79
artikel
308 Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin – A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE Andersen, Ida Vang

112-113 C p.
artikel
309 Investigation of 123I production using electron accelerator Avetisyan, Albert
2017
112-113 C p. 44-47
artikel
310 In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector Läppchen, Tilman
2018
112-113 C p. 45-54
artikel
311 In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain Kilbourn, Michael R.

112-113 C p. 38-42
artikel
312 In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab Othman, Muhamad Faiz bin

112-113 C p. 57-64
artikel
313 In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies Varlow, Cassis

112-113 C p.
artikel
314 In vitro uptake and metabolism of [14C]acetate in rabbit atherosclerotic arteries: biological basis for atherosclerosis imaging with [11C]acetate Yamasaki, Kazuaki
2018
112-113 C p. 21-25
artikel
315 In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model Jiao, Honglei
2019
112-113 C p. 31-39
artikel
316 In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration Patel, Shil

112-113 C p. 20-30
artikel
317 In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4 Renard, Isaline

112-113 C p.
artikel
318 Is logP truly dead? Kilbourn, Michael R.
2017
112-113 C p. 41-42
2 p.
artikel
319 Issues in preclinical radiopharmaceutical research: Significance, relevance and reproducibility Kilbourn, Michael R.
2018
112-113 C p. 52-55
artikel
320 Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals Klenner, Mitchell A.

112-113 C p. 112-147
artikel
321 Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713 Yasuno, Fumihiko

112-113 C p. 76-84
artikel
322 Kit-based preparation of [68Ga]Ga-P16-093 (PSMA-093) using different commercial 68Ge/68Ga generators Hong, Haiyan

112-113 C p. 1-9
artikel
323 Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy O'Neill, Edward

112-113 C p. 44-53
artikel
324 Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate Zhou, Zhengyuan

112-113 C p. 24-35
artikel
325 Laminated holmium-166-containing electrospun bandages for use against skin cancer Osipitan, Ositomiwa O.

112-113 C p. 78-85
artikel
326 LogP, a yesterday's value? Vraka, Chrysoula
2017
112-113 C p. 1-10
artikel
327 Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of 131I-labeling Wagener, Karolin
2018
112-113 C p. 59-66
artikel
328 Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer Bandara, Nilantha

112-113 C p. 71-77
artikel
329 Metabolic characteristics of [18F]fluoroboronotyrosine (FBY) PET in malignant brain tumors Kong, Ziren

112-113 C p. 80-87
artikel
330 Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides Costa, Ines M.

112-113 C p. 18-29
artikel
331 MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons Xu, Yingjiao

112-113 C p. 9-18
artikel
332 Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors Lisova, Ksenia
2018
112-113 C p. 36-44
artikel
333 Microwave-assisted synthesis of [52Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling Gawne, Peter J.

112-113 C p. 6-17
artikel
334 Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity Chegu, Anusha

112-113 C p. 70-75
artikel
335 Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders Brandt, Marie
2019
112-113 C p. 46-52
artikel
336 Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands Winter, Gordon
2019
112-113 C p. 20-25
artikel
337 Molar activity – The keystone in 11C-radiochemistry: An explorative study using the gas phase method Pichler, Verena
2018
112-113 C p. 21-26
artikel
338 Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras Jiao, Yuying

112-113 C p. 28-37
artikel
339 Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease Giron, Maria Cecilia

112-113 C p. 72-77
artikel
340 Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET Wagner, Michael
2018
112-113 C p. 51-58
artikel
341 Monitoring of macrophage accumulation in statin-treated atherosclerotic mouse model using sodium iodide symporter imaging system Yoo, Ran Ji
2017
112-113 C p. 45-51
7 p.
artikel
342 Monoanionic 99mTc-tricarbonyl-aminopolycarboxylate complexes with uncharged pendant groups: Radiosynthesis and evaluation as potential renal tubular tracers Lipowska, Malgorzata
2017
112-113 C p. 48-55
artikel
343 [99mTc]duramycin for cell death imaging: Impact of kit formulation, purification and species difference Palmieri, Luca
2018
112-113 C p. 1-9
artikel
344 99mTc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging Rezazadeh, Farzaneh

112-113 C p. 54-62
artikel
345 99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients Santos-Cuevas, Clara
2017
112-113 C p. 1-6
6 p.
artikel
346 99mTc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen Xu, Xiaoping
2017
112-113 C p. 69-75
7 p.
artikel
347 99mTc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawn Zhang, Xin
2017
112-113 C p. 44-49
artikel
348 [99mTc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy Li, Yi
2018
112-113 C p. 18-25
artikel
349 [99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers Vats, Kusum

112-113 C p.
artikel
350 [99mTc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas Vallejo-Armenta, Paola

112-113 C p. 1-8
artikel
351 Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer Sarparanta, Mirkka

112-113 C p. 1-12
artikel
352 NANOCIS®: Possible errors in the summary of product characteristics quality control method and a suggested alternative method Paludan, J.P.

112-113 C p. 1-5
artikel
353 Nanozeolite bioconjugates labeled with 223Ra for targeted alpha therapy Piotrowska, Agata
2017
112-113 C p. 10-18
artikel
354 Neutron-activatable radionuclide cancer therapy using graphene oxide nanoplatelets Kim, Junghyun
2017
112-113 C p. 42-48
7 p.
artikel
355 Neutron-activated theranostic radionuclides for nuclear medicine Tan, Hun Yee

112-113 C p. 55-68
artikel
356 New method for production of 155Tb via 155Dy by irradiation of natGd by medium energy alpha particles Moiseeva, A.N.

112-113 C p. 52-61
artikel
357 New potent A1 adenosine receptor radioligands for positron emission tomography Kreft, Sabrina
2017
112-113 C p. 69-77
9 p.
artikel
358 News ways of understanding the complex biology of diabetes using PET Eriksson, O.

112-113 C p. 65-71
artikel
359 N-(4-[18F]fluorobenzyl)cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: Radiosynthesis and proof-of-concept studies in rats Frisch, Kim
2018
112-113 C p. 56-62
artikel
360 N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/CT study in pigs Frisch, Kim

112-113 C p. 49-57
artikel
361 N-[18F]-FluoropropylJDTic for κ-opioid receptor PET imaging: Radiosynthesis, pre-clinical evaluation, and metabolic investigation in comparison with parent JDTic Schmitt, Sébastien
2017
112-113 C p. 50-61
12 p.
artikel
362 Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model Bansal, Aditya

112-113 C p. 4-11
artikel
363 Noninvasively visualize the expression of LAPTM4B protein using a novel 18F-labeled peptide PET probe in hepatocellular carcinoma Ren, Yunyan

112-113 C p. 52-60
artikel
364 [No title] Gott, Matthew

112-113 C p. 32
artikel
365 Novel application of [18F]DPA714 for visualizing the pulmonary inflammation process of SARS-CoV-2-infection in rhesus monkeys (Macaca mulatta) Meijer, Lisette

112-113 C p. 1-8
artikel
366 Novel methods for the quantification of toxic, residual phase transfer catalyst in fluorine-18 labeled radiotracers Blevins, David W.

112-113 C p. 41-48
artikel
367 Novel O-[11C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation Teyssier, Valentin R.

112-113 C p. 34-44
artikel
368 Novel pyridine-containing azacrownethers for the chelation of therapeutic bismuth radioisotopes: Complexation study, radiolabeling, serum stability and biodistribution Egorova, B.V.
2018
112-113 C p. 1-10
artikel
369 Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in pancreas Watanabe, Hiroyuki

112-113 C p. 93-97
artikel
370 Nuclear data for production and medical application of radionuclides: Present status and future needs Qaim, Syed M.
2017
112-113 C p. 31-49
19 p.
artikel
371 O-(2-18F-fluoroethyl)-l-tyrosine (18F-FET) uptake in insulinoma: first results from a xenograft mouse model and from human Imperiale, Alessio
2017
112-113 C p. 21-28
8 p.
artikel
372 On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell radiolabelling Socan, A.
2019
112-113 C p. 23-31
artikel
373 One-pot enzymatic synthesis of l-[3-11C]lactate for pharmacokinetic analysis of lactate metabolism in rat brain Temma, Takashi

112-113 C p. 28-33
artikel
374 One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging Basuli, Falguni

112-113 C p. 63-70
artikel
375 One-step 18F-fluorination of smart positron emission tomography tracer for sensing furin activity in tumors Zhao, Xueyu

112-113 C p. 72-79
artikel
376 On the applicability of [18F]FBPA to predict L-BPA concentration after amino acid preloading in HuH-7 liver tumor model and the implication for liver boron neutron capture therapy Grunewald, Catrin
2017
112-113 C p. 83-89
7 p.
artikel
377 On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion Herth, Matthias M.

112-113 C p. 19-21
artikel
378 Optimization of solid-phase extraction (SPE) in the preparation of [18F]D3FSP: A new PET imaging agent for mapping Aβ plaques Yao, Xinyue
2019
112-113 C p. 54-64
artikel
379 Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[211At]astato-benzylguanidine Ohshima, Yasuhiro

112-113 C p. 44-51
artikel
380 Outside Back Cover
112-113 C p. OBC
artikel
381 Outside Back Cover
112-113 C p. OBC
artikel
382 Outside Back Cover
112-113 C p. OBC
artikel
383 Outside Back Cover
112-113 C p. OBC
artikel
384 Outside Back Cover
112-113 C p. OBC
artikel
385 Outside Back Cover
112-113 C p. OBC
artikel
386 Outside Back Cover
112-113 C p. OBC
artikel
387 Outside Back Cover - Graphical abstract TOC
112-113 C p. OBC
artikel
388 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
389 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
390 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
391 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
392 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
393 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
394 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
395 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
396 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
397 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
artikel
398 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
artikel
399 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
artikel
400 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
artikel
401 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
artikel
402 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
artikel
403 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
artikel
404 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
artikel
405 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
artikel
406 Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours Geenen, Lorain

112-113 C p. 1-11
artikel
407 Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity Seo, Daniele
2017
112-113 C p. 57-64
artikel
408 Passive and receptor mediated brain delivery of an anti-GFAP nanobody Meier, Silvio R.

112-113 C p. 128-134
artikel
409 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models Kasten, Benjamin B.
2018
112-113 C p. 67-73
artikel
410 Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy Bongarzone, Salvatore

112-113 C p. 66-67
artikel
411 PET [11C]acetate is also a perfusion tracer for kidney evaluation purposes Normand, Gabrielle

112-113 C p. 10-14
artikel
412 PET/CT with 18F–choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients Calabria, Ferdinando
2017
112-113 C p. 40-54
15 p.
artikel
413 PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs Wong, Patty
2017
112-113 C p. 62-68
artikel
414 PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data Tang, Jie

112-113 C p. 1-9
artikel
415 PET measurement of “GABA shift” in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [18F]flumazenil Kim, Wook
2017
112-113 C p. 30-34
5 p.
artikel
416 PET studies in non-human primates: Choosing drug doses Kilbourn, Michael R.
2017
112-113 C p. 1-3
artikel
417 Plasma pharmacokinetic and metabolism of [18F]THK-5317 are dependent on sex Mairinger, Severin

112-113 C p. 28-32
artikel
418 p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the 186Re/99mTc-tricarbonyl core: Radiochemistry with model complexes and a GRPR-targeting peptide H.A. Kankanamalage, Pavithra

112-113 C p. 1-9
artikel
419 Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations Filosofov, Dmitry

112-113 C p. 1-19
artikel
420 Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb Fiaccabrino, Desiree Erika

112-113 C p. 81-91
artikel
421 Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase Estrada, Sergio

112-113 C p. 62-71
artikel
422 Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model Lien, Vegard Torp

112-113 C p. 74-80
artikel
423 Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain Zha, Zhihao

112-113 C p. 97-106
artikel
424 Preclinical evaluation of heat-denatured [18F]FDG-labeled red blood cells for detecting splenic tissues with PET in rats Matsusaka, Yohji
2018
112-113 C p. 26-30
artikel
425 Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice Aghevlian, Sadaf

112-113 C p. 8-17
artikel
426 Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model Ohshima, Yasuhiro

112-113 C p. 15-22
artikel
427 Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis Higashikawa, Kei

112-113 C p. 25-32
artikel
428 Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2 Wichmann, Christian Werner

112-113 C p.
artikel
429 Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer Hoffman, S.L.V.

112-113 C p.
artikel
430 Preclinical study of an 18F-labeled glutamine derivative for cancer imaging Li, Cong

112-113 C p. 34-40
artikel
431 Preclinical validation of [18F]2FNQ1P as a specific PET radiotracer of 5-HT6 receptors in rat, pig, non-human primate and human brain tissue Emery, Stéphane

112-113 C p. 57-63
artikel
432 Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [11C]YM155 Mitsuoka, Keisuke

112-113 C p. 41-46
artikel
433 Preferred use of curie (ci) rather than becquerel (Bq) in nuclear medicine practice Pillai, Maroor Raghavan Ambikalmajan
2017
112-113 C p. 51-52
2 p.
artikel
434 Pre-labelling versus direct labelling of anthrax proteins for imaging of matrix metalloproteinases activity using DOTA-GA Xavier, Mary-Ann Elvina
2019
112-113 C p. 49-54
artikel
435 Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer Zhou, Dong
2018
112-113 C p. 26-31
artikel
436 Preliminary evaluation of 18F-labeled LLP2A-trifluoroborate conjugates as VLA-4 (α4β1 integrin) specific radiotracers for PET imaging of melanoma Roxin, Áron
2018
112-113 C p. 11-20
artikel
437 Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to rhenium-188 labeled rituximab Azadbakht, Bakhtiar
2017
112-113 C p. 26-30
5 p.
artikel
438 Preparation and evaluation of 111In-labeled liposomes containing phosphatidylglycerol for detection of macrophages in atherosclerotic plaques Munekane, Masayuki

112-113 C p.
artikel
439 Preparation and evaluation of L- and D-5-[18F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases Tang, Tang
2017
112-113 C p. 10-17
8 p.
artikel
440 Preparation and evaluation of rhenium-188-pamidronate as a palliative treatment in bone metastasis Erfani, Mostafa
2017
112-113 C p. 1-7
artikel
441 Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb Jakobsson, Ulrika

112-113 C p. 102-110
artikel
442 Preparation and labelling of red blood cells with [68Ga]Ga-oxine for PET/CT imaging of the human spleen Drescher, Robert

112-113 C p.
artikel
443 Preparation of a multi-modal agent for sentinel lymph node mapping using Evans blue and 99mTc-labeled mannosylated human serum albumin conjugate Lee, Ji Youn

112-113 C p. 38-45
artikel
444 Preparation of [177Lu]Lu-DOTA-Ahx-Lys40-Exendin-4 for radiotherapy of insulinoma: a detailed insight into the radiochemical intricacies Guleria, Mohini

112-113 C p. 31-40
artikel
445 Preparation of 212Pb-labeled monoclonal antibody using a novel 224Ra-based generator solution Westrøm, Sara
2017
112-113 C p. 1-9
9 p.
artikel
446 Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with 119Sb Kostelnik, Thomas I.

112-113 C p.
artikel
447 Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply McIntosh, Lauren A.

112-113 C p.
artikel
448 Production of positron-emitting radionuclide yttrium-86 with a computer-aided design target for positron emission tomography Chen, Junyi

112-113 C p. 54-60
artikel
449 Production of Zr-89 using sputtered yttrium coin targets Queern, Stacy Lee
2017
112-113 C p. 11-16
artikel
450 Production, purification and availability of 211At: Near term steps towards global access Feng, Yutian

112-113 C p. 12-23
artikel
451 Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine Schillaci, Orazio
2019
112-113 C p. 66-79
artikel
452 Proton-induced production and radiochemical isolation of 44Ti from scandium metal targets for 44Ti/44Sc generator development Radchenko, Valery
2017
112-113 C p. 25-32
artikel
453 Publisher’s note
112-113 C p.
artikel
454 Quantitation of rat cerebral blood flow using 99mTc-HMPAO Suzuki, Chie
2017
112-113 C p. 19-22
artikel
455 Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody Nakata, Norihito

112-113 C p. 33-43
artikel
456 Radiation dosimetry of [18F]GP1 for imaging activated glycoprotein IIb/IIIa receptors with positron emission tomography in patients with acute thromboembolism Lee, Narae
2019
112-113 C p. 45-48
artikel
457 Radiation induced oxidation of [18F]fluorothia fatty acids under cGMP manufacturing conditions Pandey, Mukesh K.

112-113 C p. 13-23
artikel
458 Radioarsenic: A promising theragnostic candidate for nuclear medicine Sanders, Vanessa A.

112-113 C p. 184-201
artikel
459 Radiochemical and biological properties of peptides designed to interact with EGF receptor: Relevance for glioblastoma Sobral, Danielle V.

112-113 C p. 14-23
artikel
460 Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab′)2 alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib Boyle, Amanda J.

112-113 C p. 46-54
artikel
461 Radiolabeling and biological characterization of TPGS-based nanomicelles by means of small animal imaging Tesan, Fiorella Carla
2017
112-113 C p. 62-68
7 p.
artikel
462 Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu Shalgunov, Vladimir

112-113 C p. 11-21
artikel
463 Radiolabeling of PSMA-617 with 89Zr: A novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results Imura, Ryota

112-113 C p. 21-28
artikel
464 Radiolabeling with [11C]HCN for Positron emission tomography Zhou, Yu-Peng

112-113 C p. 56-86
artikel
465 Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1 Rosestedt, Maria

112-113 C p. 54-62
artikel
466 Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy Nelson, Bryce J.B.

112-113 C p. 59-66
artikel
467 Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles Pozzi, Oscar R.
2017
112-113 C p. 43-49
7 p.
artikel
468 Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation Nemieboka, Brandon

112-113 C p. 9-19
artikel
469 Radiopharmacy in Africa: current status and future directions Ekoume, F.P.

112-113 C p. 29-33
artikel
470 Radiosynthesis and biological evaluation of N-(2-[18F]fluoropropionyl)-3,4-dihydroxy-l-phenylalanine as a PET tracer for oncologic imaging Tang, Caihua
2017
112-113 C p. 39-46
artikel
471 Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1 Huang, Tianyu

112-113 C p. 18-27
artikel
472 Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands Willmann, Michael

112-113 C p. 43-52
artikel
473 Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging Wang, Hongliang

112-113 C p. 98-105
artikel
474 Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer Jackson, Isaac M.

112-113 C p. 143-150
artikel
475 Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins Bai, Ping

112-113 C p. 96-101
artikel
476 Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine Baguet, Tristan

112-113 C p. 20-29
artikel
477 Rapid and automated production of [68Ga]gallium chloride and [68Ga]Ga-DOTA-TATE on a medical cyclotron Tieu, William

112-113 C p. 12-18
artikel
478 Rapid detection of SARS-CoV-2 using a radiolabeled antibody Pirovano, Giacomo

112-113 C p. 69-75
artikel
479 Rapid, high-yield enzymatic synthesis of n.c.a. 6-[18F]fluorodopamine (6-[18F]FDA) for in vivo application Bamminger, Karsten

112-113 C p. 189-197
artikel
480 Reactive oxygen species-driven HIF1α triggers accelerated glycolysis in endothelial cells exposed to low oxygen tension Paik, Jin-Young
2017
112-113 C p. 8-14
7 p.
artikel
481 Re-assessing gallium-67 as a therapeutic radionuclide Othman, Muhamad F. bin
2017
112-113 C p. 12-18
7 p.
artikel
482 Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals Piron, Sarah

112-113 C p. 29-51
artikel
483 Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation Lipowska, Malgorzata
2018
112-113 C p. 42-50
artikel
484 Reconsider logP! Vraka, Chrysoula
2017
112-113 C p. 42-
1 p.
artikel
485 Redesign of negatively charged 111In-DTPA-octreotide derivative to reduce renal radioactivity Oshima, Nobuhiro
2017
112-113 C p. 16-25
10 p.
artikel
486 Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes Suzuki, Hiroyuki

112-113 C p.
artikel
487 Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO Nakajima, Kohei

112-113 C p. 85-92
artikel
488 Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [18F]FBEM and in vivo PET studies Dammicco, Sylvestre
2017
112-113 C p. 33-39
7 p.
artikel
489 Relationship between [14C]MeAIB uptake and amino acid transporter family gene expression levels or proliferative activity in a pilot study in human carcinoma cells: Comparison with [3H]methionine uptake Kagawa, Shinya
2017
112-113 C p. 8-15
artikel
490 Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancreatic ductal adenocarcinoma (PDAC) cells Boyle, Amanda J.

112-113 C p.
artikel
491 Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides Arano, Yasushi

112-113 C p. 149-155
artikel
492 Repeatability of brown adipose tissue activation measured by [18F]FDG PET after beta3-adrenergic stimuli in a mouse model de Paula Faria, Daniele

112-113 C p.
artikel
493 RETRACTED: Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors Sun, Penghui

112-113 C p. 1-9
artikel
494 Review on 99mTc radiopharmaceuticals with emphasis on new advancements Duatti, Adriano

112-113 C p. 202-216
artikel
495 Review: PET imaging with macro- and middle-sized molecular probes Mukai, Hidefumi

112-113 C p. 156-170
artikel
496 Robust high-yield ~1 TBq production of cyclotron based sodium [99mTc]pertechnetate Andersson, J.D.
2018
112-113 C p. 63-70
artikel
497 Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy Xu, Qinfeng

112-113 C p. 34-43
artikel
498 Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging Spahn, Muriel Aline

112-113 C p.
artikel
499 Semi-automated system for concentrating 68Ga-eluate to obtain high molar and volume concentration of 68Ga-Radiopharmaca for preclinical applications de Blois, Erik

112-113 C p. 16-21
artikel
500 Serotonin transporter imaging agent as a probe for β-cells of pancreas Sun, Yuli

112-113 C p.
artikel
501 Sex-differences in [68Ga]Ga-DOTANOC biodistribution Leisser, A.

112-113 C p. 15-20
artikel
502 Simple and rapid radiosynthesis of N-18F-labeled glutamic acid as a hepatocellular carcinoma PET tracer Sun, Aixia
2017
112-113 C p. 38-43
artikel
503 Simvastatin augments revascularization and reperfusion in a murine model of hind limb ischemia – Multimodal imaging assessment Goggi, Julian Luke
2017
112-113 C p. 25-31
7 p.
artikel
504 Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent Feng, Yutian

112-113 C p. 171-183
artikel
505 Small-scale production of 67Cu for a preclinical study via the 64Ni(α, p)67Cu channel Ohya, Tomoyuki
2018
112-113 C p. 56-60
artikel
506 Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression Xu, Jinbin

112-113 C p. 65-70
artikel
507 Somatostatin receptor targeting with hydrophilic [99mTc/186Re]Tc/Re-tricarbonyl NODAGA and NOTA complexes Makris, George
2019
112-113 C p. 39-46
artikel
508 Speed matters to raise molar radioactivity: Fast HPLC shortens the quality control of C-11 PET-tracers Nics, Lukas
2018
112-113 C p. 28-33
artikel
509 Status and future perspectives of Meitner-Auger and low energy electron-emitting radionuclides for targeted radionuclide therapy Radchenko, Valery

112-113 C p. 106
artikel
510 Status of radiobiology in molecular radionuclide therapy – Hope for the future Nonnekens, Julie

112-113 C p. 45-46
artikel
511 Status of the ‘consensus nomenclature rules in radiopharmaceutical sciences’ initiative Coenen, Heinz H.
2019
112-113 C p. 19-22
artikel
512 Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2 Luo, Zonghua

112-113 C p. 52-61
artikel
513 Synthesis and evaluation of a 99mTc-labeled chemokine receptor antagonist peptide for imaging of chemokine receptor expressing tumors Mikaeili, Azadeh
2017
112-113 C p. 10-17
8 p.
artikel
514 Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors Radford, Lauren
2017
112-113 C p. 4-9
artikel
515 Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone Hirata, Saki

112-113 C p. 34-41
artikel
516 Synthesis and evaluation of an N-[18F]fluorodeoxyglycosyl amino acid for PET imaging of tumor metabolism Wu, Zhifang
2018
112-113 C p. 40-48
artikel
517 Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor Zha, Zhihao
2018
112-113 C p. 36-47
artikel
518 Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides Suzuki, Hiroyuki

112-113 C p. 18-28
artikel
519 Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia Pees, Anna

112-113 C p. 97-105
artikel
520 Synthesis and evaluation of 6-[18F]fluoro-3-(pyridin-3-yl)-1H-indole as potential PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO) Qiao, Zheng

112-113 C p. 1-10
artikel
521 Synthesis and evaluation of [18F]FP-Lys-GE11 as a new radiolabeled peptide probe for epidermal growth factor receptor (EGFR) imaging Li, Xueli

112-113 C p. 84-92
artikel
522 Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX Nakashima, Kazuma

112-113 C p. 46-53
artikel
523 Synthesis and evaluation of 99mTc-analogues of [123/131I]mIBG prepared via [99mTc][Tc(CO)3(H2O)3]+ synthon for targeting norepinephrine transporter Das, Soumen
2019
112-113 C p. 49-57
artikel
524 Synthesis and evaluation of 99mTc/Re-tricarbonyl complexes of the triphenylphosphonium cation for mitochondrial targeting Paparidis, Georgios
2018
112-113 C p. 34-41
artikel
525 Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation Tsuchihashi, Shohei

112-113 C p.
artikel
526 Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease Lerdsirisuk, Pradith

112-113 C p. 11-18
artikel
527 Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors Lindberg, Anton
2019
112-113 C p. 1-13
artikel
528 Synthesis and evaluation of zirconium-89 labelled and long-lived GLP-1 receptor agonists for PET imaging Jacobsen, Christian Borch

112-113 C p. 49-56
artikel
529 Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics Lambidis, Elisavet

112-113 C p. 151-161
artikel
530 Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer Kwan, Kim H.

112-113 C p. 37-45
artikel
531 Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5 Rotteveel, Lonneke

112-113 C p. 9-19
artikel
532 Synthesis and preclinical evaluation of the CRTH2 antagonist [11C]MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass Eriksson, Jonas
2019
112-113 C p. 1-10
artikel
533 Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor Högnäsbacka, Antonia

112-113 C p.
artikel
534 Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer Vaidyanathan, Ganesan

112-113 C p. 67-80
artikel
535 Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides Sanders, Vanessa A.
2019
112-113 C p. 1-13
artikel
536 Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors Prause, Martin
2018
112-113 C p. 1-11
artikel
537 Synthesis of 11C-labeled DNA polymerase-β inhibitor 5-methoxyflavone and PET/CT imaging thereof Chen, Zude

112-113 C p. 17-22
artikel
538 Synthesis of [18F] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors Arisawa, Tetsu

112-113 C p. 47-58
artikel
539 Synthesis of N-(6-[18F]Fluoropyridin-3-yl)glycine as a potential renal PET agent Wang, Hongliang

112-113 C p. 21-27
artikel
540 Synthesis, radiolabeling and preclinical evaluation of a [11C]GMOM derivative as PET radiotracer for the ion channel of the N-methyl-D-aspartate receptor Klein, Pieter J.
2017
112-113 C p. 25-32
8 p.
artikel
541 Synthesis, radiolabeling, and preclinical in vivo evaluation of 68Ga-radiolabelled nanodiamonds Wanek, Thomas

112-113 C p.
artikel
542 Table of Contents 2017
112-113 C p. IBC-
1 p.
artikel
543 Table of Contents 2017
112-113 C p. IBC-
1 p.
artikel
544 Table of Contents 2017
112-113 C p. IBC-
1 p.
artikel
545 Table of Contents 2017
112-113 C p. IBC-
1 p.
artikel
546 Table of Contents 2017
112-113 C p. IBC-
1 p.
artikel
547 Table of Contents 2017
112-113 C p. IBC-
1 p.
artikel
548 Table of Contents 2018
112-113 C p. IBC
artikel
549 Table of Contents
112-113 C p. IBC
artikel
550 Table of Contents
112-113 C p. IBC
artikel
551 Table of Contents 2018
112-113 C p. IBC
artikel
552 Table of Contents 2017
112-113 C p. IBC
artikel
553 Table of Contents 2018
112-113 C p. IBC
artikel
554 Table of Contents 2017
112-113 C p. IBC-
1 p.
artikel
555 Table of Contents 2017
112-113 C p. IBC-
1 p.
artikel
556 Table of Contents 2017
112-113 C p. IBC
artikel
557 Table of Contents 2017
112-113 C p. IBC
artikel
558 Table of Contents 2017
112-113 C p. IBC
artikel
559 Table Of Contents 2018
112-113 C p. IBC
artikel
560 Table of Contents 2018
112-113 C p. IBC
artikel
561 Table of Contents 2018
112-113 C p. IBC
artikel
562 Table of Contents & Barcode 2018
112-113 C p. IBC
artikel
563 Table of Contents & Barcode 2018
112-113 C p. IBC
artikel
564 Tactics for preclinical validation of receptor-binding radiotracers Lever, Susan Z.
2017
112-113 C p. 4-30
27 p.
artikel
565 Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers Nelson, Bryce J.B.

112-113 C p. 24-31
artikel
566 Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals Rigby, Alex

112-113 C p. 1-7
artikel
567 Targeting phosphatidylethanolamine and phosphatidylserine for imaging apoptosis in cancer Li, Junling

112-113 C p. 23-30
artikel
568 Target manufacturing by Spark Plasma Sintering for efficient 89Zr production Cisternino, S.

112-113 C p. 38-46
artikel
569 The development of 11C-carbonylation chemistry: A systematic view Eriksson, Jonas

112-113 C p. 115-137
artikel
570 The effect of hypoxia on the induction of strand breaks in plasmid DNA by alpha-, beta- and Auger electron-emitters 223Ra, 188Re, 99mTc and DNA-binding 99mTc-labeled pyrene Reissig, Falco

112-113 C p. 65-70
artikel
571 The emerging role of artificial intelligence and digital twins in pre-clinical molecular imaging Currie, Geoffrey M.

112-113 C p.
artikel
572 The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy Aloj, Luigi

112-113 C p. 53-64
artikel
573 The future of the radiopharmaceutical sciences Lapi, Suzanne E.

112-113 C p.
artikel
574 The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates Jiang, Wen

112-113 C p. 1-8
artikel
575 The impact of barium isotopes in radiopharmacy and nuclear medicine – From past to presence Reissig, Falco

112-113 C p. 59-68
artikel
576 The past, present, and the promise of the future of nuclear medicine and biology Eckelman, W.C.
2017
112-113 C p. 47-48
artikel
577 The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review Katzenellenbogen, John A.

112-113 C p. 24-37
artikel
578 Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry Lin, Wilson

112-113 C p.
artikel
579 The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far Heynickx, Nathalie

112-113 C p. 30-39
artikel
580 Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy Spetz, Johan
2018
112-113 C p. 11-18
artikel
581 45Ti targeted tracers for PET imaging of PSMA Chaple, Ivis F.

112-113 C p. 16-23
artikel
582 Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies Driver, Cathryn Helena Stanford

112-113 C p. 53-66
artikel
583 Tracer development for PET imaging of proteinopathies Kallinen, Annukka

112-113 C p. 115-127
artikel
584 Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography Kirby, Alexia

112-113 C p.
artikel
585 Training the next generation of radiopharmaceutical scientists Gee, Antony D.

112-113 C p. 10-13
artikel
586 Transport mechanism and affinity of [99mTc]Tc-mercaptoacetyltriglycine ([99mTc]MAG3) on the apical membrane of renal proximal tubule cells Kobayashi, Masato

112-113 C p. 33-37
artikel
587 Tumor uptake and tumor/blood ratios for [89Zr]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1 Al-saden, Noor
2018
112-113 C p. 43-51
artikel
588 Unexpected decrease in in vivo binding of [3H]QNB in the mouse cerebral cortex in the developing brain - A comparison with [11C]NMPB Inoue, Osamu
2018
112-113 C p. 15-20
artikel
589 Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage Suzuki, Motofumi

112-113 C p. 45-55
artikel
590 Use of radiolabeled hyaluronic acid for preclinical assessment of inflammatory injury and acute respiratory distress syndrome Zhao, Fangyuan

112-113 C p. 86-98
artikel
591 Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F]FCA in mouse models of liver disease De Lombaerde, Stef
2019
112-113 C p. 40-48
artikel
592 Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy Verger, Elise

112-113 C p. 36-43
artikel
593 Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer Oh, Sera

112-113 C p. 135-142
artikel
594 Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer Xi, Yun

112-113 C p.
artikel
595 VMAT2 imaging agent, D6-[18F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization Zhao, Ruiyue
2019
112-113 C p. 26-35
artikel
596 VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation Tripathi, Sushil K.
2017
112-113 C p. 55-61
7 p.
artikel
597 What about α v β 3 integrins in molecular imaging in oncology? Debordeaux, Frederic

112-113 C p. 31-46
artikel
598 Whole-body biodistribution of the cannabinoid type 1 receptor ligand [18F]MK-9470 in the rat Buchholz, H.G.
2017
112-113 C p. 63-69
7 p.
artikel
599 William C. Eckelman: An anchor of stability with a quiet voice that nurtured a new field Katzenellenbogen, John A.

112-113 C p. 2-4
artikel
600 William C. Eckelman, an icon of radiopharmaceutical sciences Windhorst, A.D.

112-113 C p. 1
artikel
601 Women in radiopharmaceutical/radiochemical sciences Choe, Yearn Seong

112-113 C p. 108-114
artikel
602 90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres Nezami, Nariman
2018
112-113 C p. 22-28
artikel
603 89Zr for antibody labeling and in vivo studies – A comparison between liquid and solid target production Dias, Gemma M.
2018
112-113 C p. 1-7
artikel
604 [89Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure Bansal, Aditya

112-113 C p. 23-30
artikel
                             604 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland